REACH springs surprises on pharmaceutical companies
CW Briefing July 2008
Pharmaceutical manufacturers and importers have found that there is more to REACH than they first assumed. Requirements affecting intermediates and excipients are exercising the industry, as Sean Milmo reports.At first sight, many pharmaceutical companies and their chemical suppliers thought they would be only marginally affected by the REACH Regulation. Article 2.5 exempts substances from registration to the extent that they are used in...
The complete text of this article is only available to registered subscribers.
Follow this link to take a no-obligation 14 day free trial
Registered users: please log in using your Personal Access Code here:
